Rufocromomycin or streptonigrin
- Level
- Commodity
- Parent
- 51281900
- Below
- 0
- Links · KBLI
- 9
Definition
UNSPSC 51281907This classification denotes an antineoplastic antibiotic with the molecular structure C25H22N4O8, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier, 261Q3JB310 chemically known as 2-pyridinecarboxylic acid, 5-amino-6-(7-amino-5,8-dihydro-6-methoxy-5,8-dioxo-2-quinolinyl)-4-(2-hydroxy-3,4-dimethoxyphenyl)-3-methyl- but generally known as rufocromomycin, which bears US NIH Compound Identifier 5323583. European Medicines Agency schedules Rufocromomycin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10405MIG. The term RUFOCROMOMYCIN is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 29, no. 10 1975, list 15. ). Rufocromomycin or streptonigrin bears US NLM identifiers UMLS ID C0038427 and NCI Concept Code C844. SMILES: O(C1=C(OC)C=CC(=C2\C(C([NH]C(C2N)C2NC3C(CC2)C(=O)C(=C(N)C3=O)OC)C(=O)O)C)\C1=O)C.
Same parent
Under 51281900 · 12Activities that produce or sell this
KBLI · 9Inherited from family 51280000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.